StonvexLoading…
StonvexCore line items from BLNK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $26.35M | $20.78M | $103.52M | $27.05M | $28.70M |
Operating Income | Not available | $-11.78M | $-84.10M | $-451.00K | $-29.56M |
Net Income | Not available | $-11.56M | $-83.39M | $-52.75M | $-31.96M |
EPS (Diluted) | $-0.09 | $-0.08 | $-0.76 | $0.00 | $-0.28 |
Total Assets | Not available | $133.16M | $147.45M | $171.28M | $168.42M |
Total Liabilities | Not available | $79.14M | $82.96M | $80.50M | $97.67M |
Cash & Equivalents | Not available | $37.99M | $39.57M | $23.11M | $25.32M |
Free Cash Flow OCF − CapEx | Not available | $-961.00K | $-40.56M | $-35.77M | Not available |
Shares Outstanding | Not available | 143.15M | 142.13M | 114.41M | 103.10M |